These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

637 related articles for article (PubMed ID: 34807755)

  • 21. Conserved coronavirus proteins as targets of broad-spectrum antivirals.
    Melo-Filho CC; Bobrowski T; Martin HJ; Sessions Z; Popov KI; Moorman NJ; Baric RS; Muratov EN; Tropsha A
    Antiviral Res; 2022 Aug; 204():105360. PubMed ID: 35691424
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Lessons learnt from broad-spectrum coronavirus antiviral drug discovery.
    Bolinger AA; Li J; Xie X; Li H; Zhou J
    Expert Opin Drug Discov; 2024 Sep; 19(9):1023-1041. PubMed ID: 39078037
    [TBL] [Abstract][Full Text] [Related]  

  • 23. MOV10 Helicase Interacts with Coronavirus Nucleocapsid Protein and Has Antiviral Activity.
    Wang L; Sola I; Enjuanes L; Zuñiga S
    mBio; 2021 Oct; 12(5):e0131621. PubMed ID: 34517762
    [TBL] [Abstract][Full Text] [Related]  

  • 24. JIB-04 Has Broad-Spectrum Antiviral Activity and Inhibits SARS-CoV-2 Replication and Coronavirus Pathogenesis.
    Son J; Huang S; Zeng Q; Bricker TL; Case JB; Zhou J; Zang R; Liu Z; Chang X; Darling TL; Xu J; Harastani HH; Chen L; Gomez Castro MF; Zhao Y; Kohio HP; Hou G; Fan B; Niu B; Guo R; Rothlauf PW; Bailey AL; Wang X; Shi PY; Martinez ED; Brody SL; Whelan SPJ; Diamond MS; Boon ACM; Li B; Ding S
    mBio; 2022 Feb; 13(1):e0337721. PubMed ID: 35038906
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Properties of Coronavirus and SARS-CoV-2.
    Malik YA
    Malays J Pathol; 2020 Apr; 42(1):3-11. PubMed ID: 32342926
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Potent Antiviral Activity of Vitamin B12 against Severe Acute Respiratory Syndrome Coronavirus 2, Middle East Respiratory Syndrome Coronavirus, and Human Coronavirus 229E.
    Moatasim Y; Kutkat O; Osman AM; Gomaa MR; Okda F; El Sayes M; Kamel MN; Gaballah M; Mostafa A; El-Shesheny R; Kayali G; Ali MA; Kandeil A
    Microorganisms; 2023 Nov; 11(11):. PubMed ID: 38004788
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Assessment of Antiviral Coatings for High-Touch Surfaces by Using Human Coronaviruses HCoV-229E and SARS-CoV-2.
    Butot S; Baert L; Zuber S
    Appl Environ Microbiol; 2021 Sep; 87(19):e0109821. PubMed ID: 34288707
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Targeting Polyamines Inhibits Coronavirus Infection by Reducing Cellular Attachment and Entry.
    Firpo MR; Mastrodomenico V; Hawkins GM; Prot M; Levillayer L; Gallagher T; Simon-Loriere E; Mounce BC
    ACS Infect Dis; 2021 Jun; 7(6):1423-1432. PubMed ID: 32966040
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Structural-based virtual screening and in vitro assays for small molecules inhibiting the feline coronavirus 3CL protease as a surrogate platform for coronaviruses.
    Theerawatanasirikul S; Kuo CJ; Phecharat N; Chootip J; Lekcharoensuk C; Lekcharoensuk P
    Antiviral Res; 2020 Oct; 182():104927. PubMed ID: 32910955
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Neutralizing and binding activities against SARS-CoV-1/2, MERS-CoV, and human coronaviruses 229E and OC43 by normal human intravenous immunoglobulin derived from healthy donors in Japan.
    Kubota-Koketsu R; Terada Y; Yunoki M; Sasaki T; Nakayama EE; Kamitani W; Shioda T
    Transfusion; 2021 Feb; 61(2):356-360. PubMed ID: 33104267
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Molnupiravir and Its Antiviral Activity Against COVID-19.
    Tian L; Pang Z; Li M; Lou F; An X; Zhu S; Song L; Tong Y; Fan H; Fan J
    Front Immunol; 2022; 13():855496. PubMed ID: 35444647
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Recent advances in potential drug therapies combating COVID-19 and related coronaviruses-A perspective.
    Nile SH; Nile A; Jalde S; Kai G
    Food Chem Toxicol; 2021 Aug; 154():112333. PubMed ID: 34118347
    [TBL] [Abstract][Full Text] [Related]  

  • 33. A Mechanistic Review on Plant-derived Natural Inhibitors of Human Coronaviruses with Emphasis on SARS-COV-1 and SARS-COV-2.
    Guguloth SK; Lakshmi AR; Rajendran R; Rajaram K; Chinnasamy T; Huang JD; Zhang H; Senapati S; Durairajan SSK
    Curr Drug Targets; 2022; 23(8):818-835. PubMed ID: 34636297
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Picolinic acid is a broad-spectrum inhibitor of enveloped virus entry that restricts SARS-CoV-2 and influenza A virus in vivo.
    Narayan R; Sharma M; Yadav R; Biji A; Khatun O; Kaur S; Kanojia A; Joy CM; Rajmani R; Sharma PR; Jeyasankar S; Rani P; Shandil RK; Narayanan S; Rao DC; Satchidanandam V; Das S; Agarwal R; Tripathi S
    Cell Rep Med; 2023 Aug; 4(8):101127. PubMed ID: 37463584
    [TBL] [Abstract][Full Text] [Related]  

  • 35. New Phenolic Lipids from the Leaves of
    Chambon M; Herrscher C; Al Halabi D; François N; Belouzard S; Boutet S; Pham VC; Doan TMH; Séron K; Mavingui P; Litaudon M; El Kalamouni C; Apel C
    Molecules; 2023 Jul; 28(14):. PubMed ID: 37513285
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Luteolin Isolated from
    Hakem A; Desmarets L; Sahli R; Malek RB; Camuzet C; François N; Lefèvre G; Samaillie J; Moureu S; Sahpaz S; Belouzard S; Ksouri R; Séron K; Rivière C
    Molecules; 2023 May; 28(11):. PubMed ID: 37298740
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Fusion Protein Targeted Antiviral Peptides: Fragment-Based Drug Design (FBDD) Guided Rational Design of Dipeptides Against SARS-CoV-2.
    Manna S; Chowdhury T; Baindara P; Mandal SM
    Curr Protein Pept Sci; 2020; 21(10):938-947. PubMed ID: 32901582
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Natural Products Homoharringtonine and Emetine Alkaloids as SARS-CoV-2 Treatment Options.
    Sohrab SS; Suhail M; Kamal MA; Azhar EI
    Curr Pharm Des; 2021; 27(32):3444-3453. PubMed ID: 33302852
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Cell-based antiviral screening against coronaviruses: developing virus-specific and broad-spectrum inhibitors.
    Kilianski A; Baker SC
    Antiviral Res; 2014 Jan; 101():105-12. PubMed ID: 24269477
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Thapsigargin: key to new host-directed coronavirus antivirals?
    Shaban MS; Mayr-Buro C; Meier-Soelch J; Albert BV; Schmitz ML; Ziebuhr J; Kracht M
    Trends Pharmacol Sci; 2022 Jul; 43(7):557-568. PubMed ID: 35534355
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 32.